Ethos Technologies Inc. LIFE
37.13 USD -3.75 (-9.17%)
At closeNov 5, 2026, 4:00 AM EST
21.00 -16.13 -43.44%
Pre-market · Nov 5, 4:00 AM ET
36.99 Day range 40.94
9.45 52-week range 49.98
- YTD
- +120.36%
- 1 year
- +120.36%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 53.38 +43.8% upside
Now 37.13
- Target (low)
- 37.00
- Target (mean)
- 53.38
- Target (high)
- 62.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy2
- Buy6
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.39157 | 0.40108 – 0.489 | 0.00 | 0.0% | 223.37M | +102.9% | 4 |
| Next quarter | 0.67612 | 0.561 – 0.82064 | 0.42 | +61.0% | 279.46M | +44.7% | 4 |
| Current year | 1.91 | 1.78 – 2.21 | 1.40 | +36.5% | 826.37M | +113.2% | 4 |
| Next year | 2.43 | 2.11 – 2.63 | 1.91 | +27.3% | 1.10B | +33.4% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Nov 3, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 3, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 12, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Oct 1, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Aug 4, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 4, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 4, 2026 | Baird | Maintained | Outperform | Outperform |
| Aug 4, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 13, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 7, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 3, 2024 | HC Wainwright& Co. | Reiterated | Buy | Buy |
| Mar 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 21, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 10, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 21, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 5, 2023 | Oppenheimer | Downgrade | Outperform | Perform |
| May 23, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2023 | RBC Capital | Reiterated | — | Outperform |
| Apr 11, 2023 | Piper Sandler | Maintained | — | Overweight |
| Mar 10, 2023 | RBC Capital | Reiterated | — | Outperform |
| Mar 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 2, 2023 | RBC Capital | Maintained | — | Outperform |
| Feb 7, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 16, 2022 | Piper Sandler | Maintained | — | Overweight |